← back to search

Ali Manouchehrinia

Alberta Health Services · CA
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Systemic Sclerosis and Related Diseases, Peripheral Neuropathies and Disorders, and Amyotrophic Lateral Sclerosis Research.
h-index
31
citations
3,593
works
122
NIH funding
primary concept
email

Recent publications

Brain age in multiple sclerosis: a study with deep learning and traditional machine learning
Brain Communications 2025cited by 7position: middledoi
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis
Brain 2024cited by 23position: middledoi
Locus for severity implicates CNS resilience in progression of multiple sclerosis
Nature 2023cited by 217position: middledoi
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers
Multiple Sclerosis Journal - Experimental Translational and Clinical 2023cited by 13position: middledoi
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe
Therapeutic Advances in Neurological Disorders 2023cited by 5position: middledoi
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus
Lara D. Veeken 2022cited by 25position: middledoi
Treatment Switching and Discontinuation Over 20 Years in the Big Multiple Sclerosis Data Network
Frontiers in Neurology 2021cited by 40position: middledoi
Objective classification of multiple sclerosis disease course results in frequent reclassification to secondary progressive multiple sclerosis (4094)
Neurology 2021cited by 1position: middledoi
Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
Annals of Clinical and Translational Neurology 2020cited by 244position: firstdoi
Blood neurofilament light levels segregate treatment effects in multiple sclerosis
Neurology 2020cited by 139position: middledoi
Early clinical markers of aggressive multiple sclerosis
Brain 2020cited by 59position: middledoi
Comparison of the proportions of Secondary Progressive Multiple Sclerosis between three registries within the SPMS Research Collaboration Network (3977)
Neurology 2020cited by 2position: middledoi
Long-term disability progression of pediatric-onset multiple sclerosis
Neurology 2019cited by 123position: lastdoi
Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis
JAMA Neurology 2019cited by 113position: middledoi
Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades
JAMA Neurology 2019cited by 80position: middledoi
Effects of cigarette smoke on immunity, neuroinflammation and multiple sclerosis
Journal of Neuroimmunology 2018cited by 106position: middledoi
Predicting risk of secondary progression in multiple sclerosis: A nomogram
Multiple Sclerosis Journal 2018cited by 78position: firstdoi
Age Related Multiple Sclerosis Severity Score: Disability ranked by age
Multiple Sclerosis Journal 2017cited by 171position: firstdoi
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response
Brain 2017cited by 146position: middledoi
Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
Multiple Sclerosis Journal 2017cited by 103position: middledoi
The Temporal Retinal Nerve Fiber Layer Thickness Is the Most Important Optical Coherence Tomography Estimate in Multiple Sclerosis
Frontiers in Neurology 2017cited by 60position: middledoi
Cognitive function is a major determinant of income among multiple sclerosis patients in Sweden acting independently from physical disability
Multiple Sclerosis Journal 2017cited by 57position: middledoi
Importance of early treatment initiation in the clinical course of multiple sclerosis
Multiple Sclerosis Journal 2016cited by 173position: middledoi
Clinical course of multiple sclerosis: A nationwide cohort study
Multiple Sclerosis Journal 2016cited by 60position: firstdoi
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study
Multiple Sclerosis Journal 2016cited by 44position: lastdoi
Effect of Smoking Cessation on Multiple Sclerosis Prognosis
JAMA Neurology 2015cited by 169position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jan Hillert · Karolinska University Hospital17 papers (2015–2024)Tomas Olsson · Karolinska University Hospital8 papers (2015–2025)Anna Glaser · Karolinska Institutet7 papers (2016–2023)Ryan Ramanujam · Karolinska Institutet6 papers (2015–2023)Ingrid Kockum · Karolinska Institutet5 papers (2017–2025)Fredrik Piehl · Karolinska University Hospital5 papers (2017–2025)Leszek Stawiarz · Karolinska Institutet4 papers (2016–2025)Lars Alfredsson · University of Pennsylvania4 papers (2015–2024) · 3 papers (2020–2023)Rod Middleton · Swansea University3 papers (2020–2023)Jeff Rodgers · Swansea University3 papers (2020–2023)Melinda Magyari · Aarhus University3 papers (2021–2023)Richard Nicholas · Imperial College Healthcare NHS Trust3 papers (2020–2023)Carol Lines · Novartis (Switzerland)3 papers (2020–2023) · 3 papers (2020–2023)David Ellenberger · Charité - Universitätsmedizin Berlin3 papers (2020–2023)Omid Beiki · Karolinska Institutet3 papers (2016–2019) · 2 papers (2021–2023)Tim Spelman · Burnet Institute2 papers (2021–2023)Robert Carruthers · McGill University Health Centre2 papers (2017–2018)